Gregory Scott Chernack (Greg)

• Obtained summary judgment on behalf of Monsanto in a case alleging that Roundup exposure caused the development of skin cancer in federal court in Louisiana. After initially obtaining summary judgment on most of plaintiffs’ claims based upon the statute of limitations, his deposition of plaintiffs’ causation expert resulted in the exclusion of that expert and the entry of summary judgment on the entirety of the case.
• Successfully represented Novartis Pharmaceuticals Corporation in a Tegretol Innovator Liability case in the Fifth Circuit, affirming Novartis’ summary judgment victory in Johnson v. Novartis Pharm. Corp. in the Western District of Texas.
• Obtained favorable outcomes for Novartis Pharmaceuticals Corporation in numerous product liability trials regarding the medications Aredia and Zometa in multiple states, including North Carolina, New Jersey, Kentucky, and Missouri.
• Obtained a directed verdict at the end of a three week trial involving Zometa in the Eastern District of California representing Novartis Pharmaceuticals Corporation in Hill v. Novartis Pharm Corp. before the Honorable Jed Rakoff (visiting from S.D.N.Y.).
• Represented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. As many of the plaintiffs and witnesses were unable to travel to the US, he obtained their testimony in Ecuador. The case went to trial with six test plaintiffs and resulted in a complete defense verdict.
• Represented pro bono the first person to be released from prison pursuant to D.C.’s Incarceration Reduction Amendment Act.

Gregory S. (Greg) Chernack helps clients resolve complex, high-exposure disputes by cutting through legal and factual complexity, managing risk, and delivering strategic advocacy that drives successful results in challenging pharmaceutical, mass-tort, and other high-stakes litigation.

Greg’s work has concentrated on developing successful defenses to lawsuits around the country by, among other things, working with expert and company witnesses in preparation for trial and engaging in complex motions practice. This work has included the representation of pharmaceutical and vaccine manufacturers and social media companies in defending products liability lawsuits.

Notably, Greg represented Novartis Pharmaceuticals Corporation at numerous trials, including successfully arguing a motion for a directed verdict at the close of one and winning a case on its behalf before the Sixth Circuit. Greg also represented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. That case ultimately went to trial in federal court in the District of Columbia with six test plaintiffs and resulted in a complete defense verdict.

In addition to his work involving product liability cases, Greg has experience before the U.S. Supreme Court involving issues ranging from patent law to immigration regulations and other complex civil litigation matters. Greg also represented pro bono the first person to be released from prison pursuant to D.C.’s Incarceration Reduction Amendment Act. 

Greg previously served as a law clerk to the Honorable Ralph K. Winter, Chief Judge, U.S. Court of Appeals for the Second Circuit, and to the Honorable Jack B. Weinstein, Senior Judge, U.S. District Court for the Eastern District of New York. He was an Articles Editor of the Yale Law Journal and has been repeatedly invited to serve as a judge for the semifinals of the George Washington University Law School’s Van Vleck Moot Court Competition. Greg received his JD from Yale Law School.